International Journal of School and Cognitive Psychology
Open Access

Some Factors Related to Depression in Non-Small Cell Lung Cancer Patients Treated at K Hospital during 2021-2022

Le Khanh Linh^1*, Do Tuyet Mai², Tran Thi Thanh Huong³ and Pham Tuong van^{3 *}Correspondence: Le Khanh Linh, Department of Preventive Medicine, Hanoi Medical University, Hanoi, Vietnam, Email:

Author info »

Abbreviations

AOR: Adjusted Odds Ratio; COR: Crude Odds Ratio; DSM-5: Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition; NSCLC: Non-Small Cell Lung Cancer; OR: Odd Ratio; PHQ-9: Patient Health Questionnaire-9 items; QoL: Quality of Life; SF-12: 12 Item Short Form Survey; VCART: Vietnam Grants for Cancer Research and Technology

Introduction

The incidence and mortality from cancer is accelerating worldwide. According to the GLOBOCAN 2020 report, Vietnam ranks 91/185 in terms of new incidence and 50/185 in terms of mortality rate per 100,000 people. In addition, lung cancer is currently the 2^nd most common cancer worldwide when assessing common cancers and the number of cancer deaths [1].

Cancer has a long and complicated therapeutic process with high treatment costs. Moreover, when it reaches advanced stages, the patient suffers not only physical pain but also a hefty psychological impact. The most common psychological traumas among cancer patients include stress, anxiety, and depression [2]. Patients who did not undergo surgery or receive radiation therapy, were younger, or had terminal cancer were more likely to develop depression [3]. Depression also affects the effectiveness of treatment and the patient's quality of life [4].

To provide data for health authorities in assessing the status and early identification signs of depression in cancer patients. From there, timely intervention and treatment measures should be developed. This has important implications for patients during lung cancer treatment.

To contribute to improving the quality of medical services and quality of life for patients, we carried out the study "Some factors related to depression in non-small cell lung cancer patients treated at K hospital during 2021-2022”.

Materials and Methods

Study design and setting

The study was conducted on NSCLC patients being treated at K Hospital in 2021-2022 by a cross-sectional descriptive study. The study period was from 09/2021 to 09/2022 at K Hospital, Tan Trieu Campus, and Hanoi.

Recruitment: To enroll as many participants as possible, the inclusion criteria were age from 18 to 65 years who had confirmed non-small cell lung cancer diagnosis by pathology and did not have a medical history of communication problems.

Data collection and variables

The sample size selected for the study is calculated according to the formula for estimating the sample size for a proportion in the population:

In fact, 243 people were recruited to participate in the study.

Objective variables

Relevant factors were determined by the relationship between depression and the factors below according to the DSM-5:

Personal factors: Age, Gender, Living, Marital status.

Social factors: Education level, Job, Health insurance.

Cancer factors: Disease stages, Time of diagnosis, Treatment methods

Data management and analysis: Information was collected directly on the questionnaires of study subjects that had been built with a set of questions. Data were entered and monitored by Excel and processed using SPSS version 20.0 software. Data entry SPSS statistical analysis of mean, median and standard deviation. The study used p<0.05, 95% confidence interval.

Ethical considerations

The study was explained, and participants volunteered. Patients had the right to withdraw from the study at any time. Be sure to keep the information that the patient provided confidential, except where it involved harming yourself or others. Patients with severe depression at risk of suicide or behavioral disorders would be referred to a psychiatrist for treatment. The study explains depression group of psychology is unrelated to cancer treatment. All patient and treatment data were confidential and just used for research. Science Council approved VCART research, Cancer Research Institute, K Hospital. Council Decision No. 528/Decision-Preventive Medicine and Public Health, 29/12/2022, School of Preventive Medicine and Public Health, approved the baseline topic.

Results

Table 1 shows that there were 17 study participants in the depression group; those under 60 years old accounted for 65.4% of the cases, while those over 60 years old accounted for 34.6%of the cases.

Table 1: The relationship between demographic data and depression in DSM-5.

In a total of 26 patients with depression, 84.6% had a low school diploma, while 15.4% had a high school diploma or higher. All patients with depression confirmed by the DSM-5 were married, accounting for 10.7%. There was no relationship between gender, age, education levels, marital status, health insurance and depression (p>0.05).

Table 2 shows that stage IV increased the risk of depression in the DSM-5 by more than 6 times in lung cancer patients (OR=6.47; p<0.05). The majority of participants had stage IV disease, with depression accounting for 84.6%. The difference between depression in the DSM-5 and disease stages was statistically significant, and no relevant factors were found in treatments and depression in the DSM-5.

Table 2: Factors associated with disease and DSM-5.

Table 3 shows that there were large differences in the quality of life aspects of the depression group compared with the no depression group. Patients with poor QoL quality in the depression group, in which quality of life of mental health (36.94 ± 5.43) and physical health (41.78 ± 7.17) were all lower than the group without depression.

Table 3: The relationship between QoL (SF-12) characteristics and depression of the patients in the DSM-5.

Table 4 presents the factors associated with depression in NSCLC patients according to the DSM-5 through the QoL characteristics analyzed. Patients with low-quality mental health had a higher risk of developing depression than the other group. Our study found that the difference was statistically significant in most groups (p<0.05).

Table 4: The difference between QoL (SF-12) characteristics and depression of the patient in DSM-5.

Discussion

Individuals over 50 years of age and singles were more likely to develop depression [5]. This study had a lower rate of depression in lung cancer patients than Yu Lee and Pao-Yen Lin's study of 104 patients at Chang Gung Hospital in Taiwan (25%). The Yu Lee and Pao-Yen Lin study included small-cell lung cancer patients who have a worse prognosis and disease mechanism. Inflammatory cytokines increase depression risk [6]. The above factors were also demonstrated in the study of Shahedah, et al. [7] who showed that those who were married or had a partner had an average depression score of 9.42 lower than those who were single/widowed/never married/divorced.

Otherwise, our study found 26 depressed non-small cell lung cancer patients with associated factors. A total of 65.4% of individuals under 60 years of age had depression. This supported a Taiwanese study by Yu Lee and Pao-Yen Lin that found that depression was more common in young lung cancer patients [6]. The rate of depression in NSCLC patients was much higher in men than in women, which could be explained by the number of lung cancer cases predominating in men, which was consistent with many other studies [8,9]. Otherwise, young cancer patients with little life stability may be more emotionally affected than middle-aged and elderly patients [10]. Educational level was below high school (84.6%). Due to their limited awareness and coping skills, less educated cancer patients may have more psychological issues. The study also found no statistically significant correlation between gender, age, and education and patient depression rates.

In our study, stage IV lung cancer patients had a 6.47 fold higher risk of depression (OR=6.47; p<0.05). Late-informed patients often have more psychological stress, more severe physical symptoms, and a greater impact on life due to illness, increasing their risk of depression. Depression may reduce cancer treatment adherence [11]. This suggested that advanced-stage NSCLC patients, whether cause or effect, may contribute to depression and low QoL. Hence, clinicians should pay attention to early screening and support mental health care of patients with nonsmall cell lung cancer.

The analysis showed that depressed patients had a much lower quality of life than nondepressed patients. Through the analysis, patients with depression had poor QoL in physical, emotional, and general health, especially mental health (36.94 ± 5.43), compared to the group without depression (41.78 ± 7.17), which was statistically significant in most groups. Yu Lee and Pao-Yen Lin found a similar decrease in quality of life in lung cancer patients with depression compared to those without depression [6]. This result was consistent with the fact that in the study of Prapa, et al. [12] and Ostroff, et al. [13] the disease and therapyrelated adverse effects might lead to poor Quality Of Life (QoL) and increased psychological distress. Depression was independently associated with poor prognosis, treatment adherence, and QoL [14,15]. These findings support the clinical approach and improve QoL in Non-Small Cell Lung Cancer (NSCLC) patients.

Conclusion

No relevant factors were found in the characteristics of gender, age, living, education level, marital status and health insurance. The difference between depression in the DSM-5 and disease stages was statistically significant at p<0.05, and patients with stage IV disease had a more than 6-fold increased risk of depression in the DSM-5 in lung cancer patients (OR=6.47; p<0.05). The difference was statistically significant in most groups for quality of life characteristics (p<0.05). In particular, patients with low quality of mental health had a higher risk of depression than the other group.

References

1. Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209-249.

   [Crossref] [Google Scholar] [PubMed]

2. Unseld M, Zeilinger EL, Fellinger M, Lubowitzki S, Krammer K, Nader IW, et al. Prevalence of pain and its association with symptoms of post‐traumatic stress disorder, depression, anxiety and distress in 846 cancer patients: A cross sectional study. Psychooncology. 2021;30(4):504-510.

   [Crossref] [Google Scholar] [PubMed]

3. Yan X, Chen X, Li M, Zhang P. Prevalence and risk factors of anxiety and depression in Chinese patients with lung cancer: A cross-sectional study. Cancer Manag Res. 2019:4347-4356.

   [Crossref] [Google Scholar] [PubMed]

4. McFarland DC, Jutagir DR, Miller AH, Breitbart W, Nelson C, Rosenfeld B. Tumor mutation burden and depression in lung cancer: association with inflammation. J Natl Compr Canc Netw. 2020;18(4):434-442.

   [Crossref] [Google Scholar] [PubMed]

5. Geddes JR, Andreasen NC. New Oxford textbook of psychiatry. Oxford University Press. 2020.

   [Google Scholar]

6. Lee Y, Lin PY, Lin MC, Wang CC, Lu HI, Chen YC, et al. Morbidity and associated factors of depressive disorder in patients with lung cancer. Cancer Manag Res. 2019:7587-7596.

   [Crossref] [Google Scholar] [PubMed]

7. Shahedah KK, How SH, Jamalludin AR, Faiz MM, Kuan YC, Ong CK. Depressive symptoms in newly diagnosed lung carcinoma: Prevalence and associated risk factors. Tuberc Respir Dis (Seoul). 2019;82(3):217-226.

   [Crossref] [Google Scholar] [PubMed]

8. Wu XN, Su D, Li HP, Wang WL, Wu WQ, Yang YJ, et al. Relationship between the depression status of patients with resectable non-small cell lung cancer and their family members in China. Eur J Oncol Nurs. 2013;17(5):668-672.

   [Crossref] [Google Scholar] [PubMed]

9. Huang X, Zhang TZ, Li GH, Liu L, Xu GQ. Prevalence and correlation of anxiety and depression on the prognosis of postoperative non-small-cell lung cancer patients in North China. Medicine (Baltimore). 2020;99(11): e19087.

   [Crossref] [Google Scholar] [PubMed]

10. Polanski J, Jankowska-Polanska B, Rosinczuk J, Chabowski M, Szymanska-Chabowska A. Quality of life of patients with lung cancer. Onco Targets Ther. 2016:1023-1028.

    [Google Scholar]

11. Richardson JL, Shelton DR, Krailo M, Levine AM. The effect of compliance with treatment on survival among patients with hematologic malignancies. J Clin Oncol. 1990;8(2):356-364.

    [Crossref] [Google Scholar] [PubMed]

12. Prapa P, Papathanasiou IV, Bakalis V, Malli F, Papagiannis D, Fradelos EC. Quality of life and psychological distress of lung cancer patients undergoing chemotherapy. World J Oncol. 2021;12(2-3):61-66.

    [Crossref] [Google Scholar] [PubMed]

13. Ostroff JS, Krebs P, Coups EJ, Burkhalter JE, Feinstein MB, Steingart RM, et al. Health-related quality of life among early-stage, non-small cell, lung cancer survivors. Lung Cancer. 2011;71(1):103-108.

    [Crossref] [Google Scholar] [PubMed]

14. Arrieta Ó, Angulo LP, Núñez-Valencia C, Dorantes-Gallareta Y, Macedo EO, Martínez-López D, et al. Association of depression and anxiety on quality of life, treatment adherence, and prognosis in patients with advanced non-small cell lung cancer. Ann Surg Oncol. 2013;20:1941-1948.

    [Crossref] [Google Scholar] [PubMed]

15. Cho Y, Lee JK, Kim DH, Park JH, Choi M, Kim HJ, et al. Factors associated with quality of life in patients with depression: A nationwide population-based study. PloS one. 2019;14(7):e0219455.

    [Crossref] [Google Scholar] [PubMed]